Charles Laverty To Speak At The FON Luncheon

  • -
Chief Executive Officer Charles Laverty to Speak at FON Luncheon

Charles Laverty To Speak At The FON Luncheon

Please Join Us

Come join Advanced Bifurcation Systems Chief Executive Officer Charles Laverty for a presentation on how the ABS Mother-Daughter platform is the only platform to treat all bifurcations.

The event is being held at Lucques in West Hollywood California on October 17th from noon until 2pm.

The event is being organized by Family Office Networks.  You may RSVP here.

Charles Laverty Presentation For

BIFURCATION DISEASE FOR A DISRUPTIVE TECHNOLOGY

8474 Melrose Avenue

West Hollywood, CA


  • -
New Heart Technologies in Battle post by Charles Laverty for ABS

Innovative Technologies Fight the World’s Top Killer

Technologies In Battle

Heart disease can strike when least expected. Almost everyone knows someone who has suffered from a heart attack or a stroke. At present, heart disease is still the number one killer in the world. But new technologies hold promise and are likely to revolutionize healthcare.

Mobile health technology is being seen as an affordable way to address risks associated with heart disease such as high blood pressure and excess weight. Studies have shown how patients responded to text messages of advice, support, and motivation, managing to meet their targets faster than control groups.

There is even a smartphone app that is able to measure how much blood the heart pumps with each beat. It can do this as well as an ultrasound.

Analyzing The Eye

Google scientists have found a way to assess the risk of heart disease by using machine learning. They have software that can analyze the back of a patient’s eye and establish the likelihood of a person suffering a cardiac event. This is not being used in clinical settings yet because further research is needed.

The NHS is planning to start using AI to diagnose scans this year. An AI system was developed at John Radcliffe Hospital that makes a possible more accurate diagnosis of scans.

With AI comes the ability to accumulate and analyze great quantities of medical data and improve on existing diagnostic procedures. In turn, patients benefit from receiving the right treatment at the right time which can improve their outlook.

A Simple Day Procedure

Our own dual catheter system has the potential to transform the way bifurcate lesions are treated, turning this into a simple day procedure rather than a complex, risky operation. Once again, the patient will benefit from less downtime and see better results.

The use of these new technologies could have a powerful impact on our lives, increasing life expectancy and reducing heart disease fatalities. They could mean the difference between life and death.


  • -
Charles Laverty Mission and ABS

Charles Laverty Article for BioSpace

Charles Laverty’s Mission With ABS

Our CEO, Charles Laverty, writes for the site BioSpace.  His mission and ours is to educate people on the possible alternative to open heart surgery.

Heart Surgery is what we are striving to save many people from.  Our medical device has already received many patents.  We have also applied for FDA approval.

Saving people from going through this very traumatic procedure and very costly procedure is our mission.

The article can be found here.


  • -
Charlie Laverty and Axcessnews

Raising Further Funds Story With Charlie Laverty by Axcessnews

Melissa Thompson of Axcessnews.com did a story with our CEO Charlie Laverty on how we are raising more funds for our company.  These funds will in turn, be life saving for a lot of people.

You can read the full article here.


  • -
Tech To Manage Heart Disease

New Tech Helps Manage Heart Disease

New Technology to Help with Health

You see a lot of people wearing pieces of technology to help them stay fit.  In staying fit, this in turn, helps people manage heart disease.

Manage Heart Disease Daily

From Fitbits and Garmins to phone apps, these are just a part of the new technology to help people.  We have created a new stent system that is helping people tremendously with their heart disease.

Our CEO, Charles Laverty, wrote about this topic for Newswire and you can find the article here.